Company Filing History:
25 out of 309 
6 out of 11 
1 out of 5,272 Years Active: 2015-2025
Title: Eric Anthony Schepis: Innovator in Neurological Devices
Introduction
Eric Anthony Schepis is a prominent inventor based in Alpharetta, GA, known for his groundbreaking work in the field of neuromodulation. With a remarkable portfolio of 28 patents, Schepis has significantly contributed to advancements in medical technology, particularly related to pain management and catheter guidance systems.
Latest Patents
Schepis's latest patents highlight his innovative approach to addressing medical challenges. One such patent is a device and method to modulate a nervous system structure to non-invasively and non-destructively inhibit nervous signaling. This system is designed to treat head-and-face pain by delivering electrical stimulation transcutaneously to targeted neural and non-neural tissue, ultimately inhibiting nervous signaling and the perception of pain. Another notable patent is aimed at muscle stimulation and/or impedance measurement for verifying proper tube placement. This invention involves a tubing assembly for electronic catheter guidance systems, which includes a catheter and a stimulation electrode assembly configured to deliver electrical stimulation to tissue, ensuring accurate placement within a patient's digestive tract.
Career Highlights
Throughout his career, Eric Anthony Schepis has made significant strides in medical technology. He has worked with leading companies such as Avent, Inc. and Soin Neuroscience, LLC, where he has likely honed his skills and contributed to the development of relevant technologies.
Collaborations
Collaboration has been a substantial aspect of Schepis's career. He has worked alongside notable colleagues such as Phillip A. Schorr and Amol Soin, both of whom have contributed valuable insights and expertise to their joint endeavors in the field of neuromodulation and medical innovation.
Conclusion
Eric Anthony Schepis stands out as a visionary inventor dedicated to improving healthcare through neuromodulation technologies. His impressive array of patents not only showcases his innovative capabilities but also reflects his commitment to enhancing the quality of patient care. With continued collaboration and research, Schepis is poised to make even greater contributions to the field in the years to come.